Company Filing History:
Years Active: 2008-2010
Title: The Innovations of Sangmin Yun
Introduction
Sangmin Yun is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods for preparing clopidogrel. With a total of 4 patents to his name, Yun's work has had a considerable impact on the industry.
Latest Patents
Yun's latest patents include innovative methods for the preparation of clopidogrel and its intermediates. One of his patents describes a process where optically pure clopidogrel can be prepared in high yield by optically resolving a racemic form of the compound using an optically active amine. This process results in the formation of the optically active form of the compound or its acid-addition salt, followed by methylation of the compound. This method enhances the efficiency and effectiveness of clopidogrel production.
Career Highlights
Sangmin Yun is currently associated with Hanmi Pharm. Co., Ltd., a leading pharmaceutical company in South Korea. His work at Hanmi Pharm has allowed him to focus on innovative drug development and contribute to advancements in the pharmaceutical sector.
Collaborations
Yun has collaborated with several talented individuals in his field, including coworkers Eun Sook Kim and Bo Sung Kwon. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.
Conclusion
Sangmin Yun's contributions to the pharmaceutical industry through his patents and collaborative efforts highlight his role as an influential inventor. His innovative methods for preparing clopidogrel demonstrate his commitment to advancing medical science and improving patient outcomes.